Hashimoto’s thyroiditis in an Egyptian cohort: clinical, functional, and ultrasonographic features with insights into nodule risk
Frontiers in Endocrinology · 2025
DOI: 10.3389/fendo.2025.1664047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2025. Verfasst von Aliaa El Aghoury und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Hashimoto Disease, Thyroid Nodule. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah Bint Abdulrahman University.
Abstract (Originalsprache)
Background/aim Hashimoto’s thyroiditis (HT) is a highly prevalent autoimmune disorder. Its coexistence with benign and malignant thyroid nodules is well-documented; however, data from non-Western countries remain limited. Our objectives were to determine the demographics, clinical presentation, biochemical parameters, and thyroid ultrasonographic findings in an Egyptian cohort with HT; estimate nodule prevalence; and identify potential risk factors for nodular presentation. Patients and methods A cross-sectional study was conducted on 408 newly diagnosed patients with HT at Alexandria University Hospital. Sociodemographic, clinical presentation, biochemical (thyroid function and autoantibodies thyroperoxidase and thyroglobulin Abs), and ultrasonographic data were collected. Thyroid nodules were classified according to the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS). Fine-needle aspiration cytology (FNAC) was classified by the Bethesda system (BSRTC). Multiple logistic regression identified predictors of nodularity.
Results
Among our cohort of 408 participants (female-to-male ratio of 15:1; mean age 38.6 years), 23.5% had thyroid nodules on ultrasound. Nodules were more frequent in those ≥35 years and with a family history of thyroid disease. Compressive symptoms were more common in the nodular group (33.0% vs. 18.6%). Hypothyroidism was observed in 80.9%, predominantly subclinical, and was more frequent in the non-nodular group (80.4% vs. 71.1%). Autoantibodies tested positive in 87.5%. One-third had diffuse enlargement; most nodules were classified as TIRADS 3 or 4. FNAC ( n = 49) showed 63.2% benign, 32.7% indeterminate, and 4.1% non-diagnostic. Histopathology ( n = 18) identified papillary thyroid cancer in 44.4%. In multiple logistic regression, age 35–50 (OR = 7.023, 95% CI: 1.447–334.090), age ≥50 (OR = 8.589, 95% CI: 1.740–42.402), family history of goiter/thyroid cancer (OR = 5.177, 95% CI: 1.055–25.403), lower TSH (OR = 0.981, 95% CI: 0.966–0.997), TPOAb (OR = 0.998, 95% CI: 0.997–0.999), and larger thyroid volume (OR = 1.036, 95% CI: 1.012–1.060) were independent predictors of nodularity.
Conclusion
HT shows heterogeneous clinical presentations, with subclinical hypothyroidism predominating. Compressive symptoms are more common in patients with nodules. Ultrasound and FNAC are essential for the management of nodules with HT and can help prevent unnecessary surgery. Older age, larger thyroid volume, and a positive familial history of goiter and/or thyroid cancer are major predictors for nodularity. The malignancy rate is ~2%, with microcalcifications strongly associated with malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt.
- Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Department of General Surgery, Endocrine Surgery Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Department of Endocrinology and Metabolism, University of Missouri, Columbia, MO, United States.
Förderung
- Princess Nourah Bint Abdulrahman University
Zitieren
APA
El Aghoury, A., Abd ElHafeez, S., El Sabaa, B., Abo El Wafa, R., Abo El Wafa, W., El Naggar, H., Ibrahim, E., Naguib, R., & Bondok, M. (2025). Hashimoto’s thyroiditis in an Egyptian cohort: clinical, functional, and ultrasonographic features with insights into nodule risk. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2025.1664047
Vancouver
El Aghoury A, Abd ElHafeez S, El Sabaa B, Abo El Wafa R, Abo El Wafa W, El Naggar H, et al. Hashimoto’s thyroiditis in an Egyptian cohort: clinical, functional, and ultrasonographic features with insights into nodule risk. Frontiers in Endocrinology. 2025. doi:10.3389/fendo.2025.1664047
BibTeX
@article{ElAghoury2025,
author = {El Aghoury, Aliaa and Abd ElHafeez, Samar and El Sabaa, Basma and Abo El Wafa, Reham and Abo El Wafa, Waleed and El Naggar, Hanaa and Ibrahim, Eiman and Naguib, Rania and Bondok, Maha},
title = {Hashimoto’s thyroiditis in an Egyptian cohort: clinical, functional, and ultrasonographic features with insights into nodule risk},
journal = {Frontiers in Endocrinology},
year = {2025},
doi = {10.3389/fendo.2025.1664047}
}
EUVIMED